On December 8, É«¿Ø´«Ã½ submitted comments to the Federal Trade Commission (FTC) for the official record of an FTC workshop held in early November on ways to promote greater competition in prescription drug markets—as a way to both reduce costs and improve access to drugs and treatments.
Resources
É«¿Ø´«Ã½ Comment Letter to FTC on Competition in Prescription Drug Markets
Comment Letter
Document Info
Published on Dec 8, 2017
Download and read the full Resource.
- Related Issues
- High-Price Drugs